 | • レポートコード：MRC23Q38852 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の血管同種移植市場について調査・分析し、世界の血管同種移植市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（皮質同種移植片、海綿状同種移植片、皮質海綿状同種移植片）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Medtronic、CryoLife、LeMaitre、LifeNet Health、DePuy Synthes、Anika Therapeutics、Stryker、NuVasive、Bioventusなどが含まれています。 世界の血管同種移植市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、血管同種移植市場規模を推定する際に考慮しました。本レポートは、血管同種移植の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、血管同種移植に関するビジネス上の意思決定に役立てることを目的としています。 ・血管同種移植市場の概要 - 製品の定義 - 血管同種移植のタイプ別セグメント - 世界の血管同種移植市場規模：タイプ別分析（皮質同種移植片、海綿状同種移植片、皮質海綿状同種移植片） - 血管同種移植の用途別セグメント - 世界の血管同種移植市場規模：用途別分析（病院、クリニック、その他） - 世界の血管同種移植市場規模予測（2018年-2029年） - 血管同種移植の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 血管同種移植市場の競争状況およびトレンド ・血管同種移植の地域別市場規模 - 北米の血管同種移植市場規模（2018年-2029年） - アメリカの血管同種移植市場規模（2018年-2029年） - ヨーロッパの血管同種移植市場規模（2018年-2029年） - アジア太平洋の血管同種移植市場規模（2018年-2029年） - 中国の血管同種移植市場規模（2018年-2029年） - 日本の血管同種移植市場規模（2018年-2029年） - 韓国の血管同種移植市場規模（2018年-2029年） - インドの血管同種移植市場規模（2018年-2029年） - オーストラリアの血管同種移植市場規模（2018年-2029年） - 中南米の血管同種移植市場規模（2018年-2029年） - 中東・アフリカの血管同種移植市場規模（2018年-2029年） ・タイプ別セグメント：皮質同種移植片、海綿状同種移植片、皮質海綿状同種移植片 - 世界の血管同種移植のタイプ別販売量（2018年-2023年） - 世界の血管同種移植のタイプ別売上（2018年-2023年） - 世界の血管同種移植のタイプ別価格 ・用途別セグメント：病院、クリニック、その他 - 世界の血管同種移植の用途別販売量（2018年-2023年） - 世界の血管同種移植の用途別売上（2018年-2023年） - 世界の血管同種移植の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Medtronic、CryoLife、LeMaitre、LifeNet Health、DePuy Synthes、Anika Therapeutics、Stryker、NuVasive、Bioventus ・産業チェーンと販売チャネルの分析 - 血管同種移植産業チェーン分析 - 血管同種移植の主要原材料 - 血管同種移植の販売チャネル - 血管同種移植のディストリビューター - 血管同種移植の主要顧客 ・血管同種移植市場ダイナミクス - 血管同種移植の業界動向 - 血管同種移植市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Vascular Allografts market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Vascular Allografts is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Vascular Allografts is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Vascular Allografts include Medtronic, CryoLife, LeMaitre, LifeNet Health, DePuy Synthes, Anika Therapeutics, Stryker, NuVasive and Bioventus, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vascular Allografts, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vascular Allografts.
The Vascular Allografts market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Vascular Allografts market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vascular Allografts manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Medtronic
CryoLife
LeMaitre
LifeNet Health
DePuy Synthes
Anika Therapeutics
Stryker
NuVasive
Bioventus
Segment by Type
Cortical Allograft
Cancellous Allograft
Corticocancellous Allograft
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vascular Allografts manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vascular Allografts in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Vascular Allografts Market Overview
1.1 Product Overview and Scope of Vascular Allografts
1.2 Vascular Allografts Segment by Type
1.2.1 Global Vascular Allografts Market Value Comparison by Type (2023-2029)
1.2.2 Cortical Allograft
1.2.3 Cancellous Allograft
1.2.4 Corticocancellous Allograft
1.3 Vascular Allografts Segment by Application
1.3.1 Global Vascular Allografts Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Vascular Allografts Market Size Estimates and Forecasts
1.4.1 Global Vascular Allografts Revenue 2018-2029
1.4.2 Global Vascular Allografts Sales 2018-2029
1.4.3 Global Vascular Allografts Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Vascular Allografts Market Competition by Manufacturers
2.1 Global Vascular Allografts Sales Market Share by Manufacturers (2018-2023)
2.2 Global Vascular Allografts Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Vascular Allografts Average Price by Manufacturers (2018-2023)
2.4 Global Vascular Allografts Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Vascular Allografts, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vascular Allografts, Product Type & Application
2.7 Vascular Allografts Market Competitive Situation and Trends
2.7.1 Vascular Allografts Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vascular Allografts Players Market Share by Revenue
2.7.3 Global Vascular Allografts Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vascular Allografts Retrospective Market Scenario by Region
3.1 Global Vascular Allografts Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Vascular Allografts Global Vascular Allografts Sales by Region: 2018-2029
3.2.1 Global Vascular Allografts Sales by Region: 2018-2023
3.2.2 Global Vascular Allografts Sales by Region: 2024-2029
3.3 Global Vascular Allografts Global Vascular Allografts Revenue by Region: 2018-2029
3.3.1 Global Vascular Allografts Revenue by Region: 2018-2023
3.3.2 Global Vascular Allografts Revenue by Region: 2024-2029
3.4 North America Vascular Allografts Market Facts & Figures by Country
3.4.1 North America Vascular Allografts Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Vascular Allografts Sales by Country (2018-2029)
3.4.3 North America Vascular Allografts Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vascular Allografts Market Facts & Figures by Country
3.5.1 Europe Vascular Allografts Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Vascular Allografts Sales by Country (2018-2029)
3.5.3 Europe Vascular Allografts Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vascular Allografts Market Facts & Figures by Country
3.6.1 Asia Pacific Vascular Allografts Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Vascular Allografts Sales by Country (2018-2029)
3.6.3 Asia Pacific Vascular Allografts Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vascular Allografts Market Facts & Figures by Country
3.7.1 Latin America Vascular Allografts Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Vascular Allografts Sales by Country (2018-2029)
3.7.3 Latin America Vascular Allografts Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vascular Allografts Market Facts & Figures by Country
3.8.1 Middle East and Africa Vascular Allografts Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Vascular Allografts Sales by Country (2018-2029)
3.8.3 Middle East and Africa Vascular Allografts Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vascular Allografts Sales by Type (2018-2029)
4.1.1 Global Vascular Allografts Sales by Type (2018-2023)
4.1.2 Global Vascular Allografts Sales by Type (2024-2029)
4.1.3 Global Vascular Allografts Sales Market Share by Type (2018-2029)
4.2 Global Vascular Allografts Revenue by Type (2018-2029)
4.2.1 Global Vascular Allografts Revenue by Type (2018-2023)
4.2.2 Global Vascular Allografts Revenue by Type (2024-2029)
4.2.3 Global Vascular Allografts Revenue Market Share by Type (2018-2029)
4.3 Global Vascular Allografts Price by Type (2018-2029)
5 Segment by Application
5.1 Global Vascular Allografts Sales by Application (2018-2029)
5.1.1 Global Vascular Allografts Sales by Application (2018-2023)
5.1.2 Global Vascular Allografts Sales by Application (2024-2029)
5.1.3 Global Vascular Allografts Sales Market Share by Application (2018-2029)
5.2 Global Vascular Allografts Revenue by Application (2018-2029)
5.2.1 Global Vascular Allografts Revenue by Application (2018-2023)
5.2.2 Global Vascular Allografts Revenue by Application (2024-2029)
5.2.3 Global Vascular Allografts Revenue Market Share by Application (2018-2029)
5.3 Global Vascular Allografts Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Vascular Allografts Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 CryoLife
6.2.1 CryoLife Corporation Information
6.2.2 CryoLife Description and Business Overview
6.2.3 CryoLife Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CryoLife Vascular Allografts Product Portfolio
6.2.5 CryoLife Recent Developments/Updates
6.3 LeMaitre
6.3.1 LeMaitre Corporation Information
6.3.2 LeMaitre Description and Business Overview
6.3.3 LeMaitre Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.3.4 LeMaitre Vascular Allografts Product Portfolio
6.3.5 LeMaitre Recent Developments/Updates
6.4 LifeNet Health
6.4.1 LifeNet Health Corporation Information
6.4.2 LifeNet Health Description and Business Overview
6.4.3 LifeNet Health Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LifeNet Health Vascular Allografts Product Portfolio
6.4.5 LifeNet Health Recent Developments/Updates
6.5 DePuy Synthes
6.5.1 DePuy Synthes Corporation Information
6.5.2 DePuy Synthes Description and Business Overview
6.5.3 DePuy Synthes Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.5.4 DePuy Synthes Vascular Allografts Product Portfolio
6.5.5 DePuy Synthes Recent Developments/Updates
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Corporation Information
6.6.2 Anika Therapeutics Description and Business Overview
6.6.3 Anika Therapeutics Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Anika Therapeutics Vascular Allografts Product Portfolio
6.6.5 Anika Therapeutics Recent Developments/Updates
6.7 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Stryker Vascular Allografts Product Portfolio
6.7.5 Stryker Recent Developments/Updates
6.8 NuVasive
6.8.1 NuVasive Corporation Information
6.8.2 NuVasive Description and Business Overview
6.8.3 NuVasive Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.8.4 NuVasive Vascular Allografts Product Portfolio
6.8.5 NuVasive Recent Developments/Updates
6.9 Bioventus
6.9.1 Bioventus Corporation Information
6.9.2 Bioventus Description and Business Overview
6.9.3 Bioventus Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bioventus Vascular Allografts Product Portfolio
6.9.5 Bioventus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vascular Allografts Industry Chain Analysis
7.2 Vascular Allografts Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vascular Allografts Production Mode & Process
7.4 Vascular Allografts Sales and Marketing
7.4.1 Vascular Allografts Sales Channels
7.4.2 Vascular Allografts Distributors
7.5 Vascular Allografts Customers
8 Vascular Allografts Market Dynamics
8.1 Vascular Allografts Industry Trends
8.2 Vascular Allografts Market Drivers
8.3 Vascular Allografts Market Challenges
8.4 Vascular Allografts Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer